Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/naloxone prolonged-release versus oxycodone prolonged-release for opioid-induced constipation and pain control
2010-021995-27Phase 3Completed
- Sponsor
- Mundipharma Research
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxycodone + naloxone and oxycodone in cancer pain (2 arms), sponsored by Mundipharma Research. Primary endpoint: Assessment of constipation symptoms through measurement of Bowel Function. Started May 2011; status: completed.
02
Drugs
oxycodone + naloxoneoxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2010-021995-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021995-27.